TIME
5th INTERNATIONAL CONGRESS ON LEUKEMIA LYMPHOMA MYELOMA
MAY 21, 2015
MEETİNG HALL A
AMGEN
MEET THE EXPERT (Meet The Hall)
Providing Best Options for Myeloma Treatment
Modeator: Hayri Güner (Dokuz Eylül University, Izmir, Turkey)
*Speaker: Shaji Kumar (Mayo Clinic, Rochestar, USA)
07:00 - 08:15
ACUTE MYELOID LEUKEMIA
Scientific Chair : Martin Tallman (Memorial Sloan-Kettering Cancer Center, New York , USA)
Muhit Özcan (Ankara University, Ankara, Turkey)
08:30-10:00
*Molecular Pathogenesis and Therapy of AML Driven By Mutations and Epigenetic Modifiers: Mark Levis (Johns
Hopkins University, Baltimore, USA)
*Are Novel Therapeutic Strategies Changing the Natural History of AML?: Martin Tallman (Memorial Sloan-Kettering
Cancer Center, New York , USA)
*Who Should Be Transplanted for AML, and How?: Jacob M. Rowe (Shaare Zedek Medical Center, Jerusalem, Israel)
COFFEE BREAK
10:00 - 10:30
MULTIPLE MYELOMA
Scientific Chair: Angela Dispenzieri (Mayo Clinic, Rochestar, USA)
Hayri Özsan (Dokuz Eylül University, Izmir, Turkey)
10:30 - 12:00
* Should We Treat SMM? : Angela Dispenzieri (Mayo Clinic, Rochestar, USA), Morie A Gertz (Mayo Clinic, Rochestar,
USA)
*Should Continuous Therapy Be Used in All Patients? : Morie A Gertz (Mayo Clinic, Rochestar, USA), Angela Dispenzieri
(Mayo Clinic, Rochestar, USA)
*Treating Relapsed Disease : Shaji Kumar (Mayo Clinic, Rochestar, USA)
12:00 - 14:00
LUNCH
SATELLITE SYMPOSIUM / NOVARTIS
*Management of CML; Clinical Monitoring, Decision Points and Strategies:
Richard Clark (UC San Diego School of Medicine, San Diego, USA)
12:30 - 13:30
DIFFUSE LARGE B-CELL LYMPHOMA
Scientific Chair : Christian Gisselbrecht ( Hôpital Saint Louis, Paris, France)
Levent Ündar ( Akdeniz University, Antalya, Turkey)
14:00 - 15:30
*Biopathology of DLBCL in Clinical Practice: Philippe Gaulard (Hôpital Henri Mondor, Creteil, France)
*What Can We Expect With New Drugs in DLBCL?: Anas Younes ( The University of Texas Anderson Cancer Center,
Houston, USA)
*How To Optimize Treatment in Various DLBCL? : Christian Gisselbrecht (Hôpital Saint Louis, Paris, France)
15:30 - 16:00
COFFEE BREAK
CUTTING EDGE ADVANCES IN MYELOPROLIFERATIVE NEOPLASMS
Scientific Chair : Ayalew Tefferi (Mayo Clinic, Minnesota, USA)
Reyhan Diz Küçükkaya (Istanbul Bilim University, Istanbul, TURKEY)
16:00 - 17:30
*Clonal Origination and Evolution in MPN: Radek Skoda (University Hospital Basel, Basel, Switzerland)
*Current Prognostication and Treatment of ET, PV and PMF: Ayalew Tefferi (Mayo Clinic, Minnesota, USA)
*Contemporary Science and Practice in Mast Cell and Eosinophilic Disorders: Animesh Pardanani (Mayo Clinic
Rochester, Minnesota, USA)
18:00-19:00
OPENING CEREMONY
POSTER DISCUSSION
TIME
07:00- 08:15
5th INTERNATIONAL CONGRESS ON LEUKEMIA LYMPHOMA MYELOMA
MAY 22, 2015
MEETİNG HALL A
GSK
MEET THE EXPERT (Meet The Expert Hall)
ACUTE LYMPHOBLASTIC LEUKEMIA
Scientific Chair: Nicola Gökbuget (J.W. Goethe University Hospital, Frankfurt, Germany)
Siret Ratip ( Acıbadem Kozyatagı Hospital, İstanbul)
08:30-10:00
*Molecular Characterization of ALL: New Markers and Subgroups : Sabina Chiaretti (Sapienza
University, Roma, Italy)
*Modern Management of Adult ALL : Nicola Gökbuget (J.W. Goethe University Hospital, Frankfurt,
Germany)
*Optimal Treatment of Ph-positive ALL: Role of TK Inhibitors and Stem Cell Transplantation : Josep
Ribera (Institut Català d'Oncologia-Hospital, Badalona, Spain)
COFFEE BREAK
10:00 - 10:30
HODGKIN LYMPHOMA
Scientific Chair: Andreas Engert (German Hodgkin Study Group (GHSG), Germany)
Rauf Haznedar (Gazi University, Ankara)
10:30 - 12:00 *Controversies In Early-Stage Hodgkin Lymphoma: Marc Andre (UCL de Mont Godinne, Yvoir, Belgium)
*Controversies In Advanced-Stage Hodgkin Lymphoma: Andreas Engert (German Hodgkin Study Group
(GHSG), Germany)
*New Drug For Relapsed Hodgkin Lymphoma: Bastian Von Tresckow (University Hospital Cologne,
Cologne, Germany)
12:00 - 14:00
12:30 - 13:30
LUNCH
SATELLITE SYMPOSIUM / GILEAD
Moderator : Onder Arslan (Ankara University, Ankara, Turkey)
*Speaker: Paolo Ghia (University in Torino, Italy)
*Speaker: Onder Arslan (Ankara University, Ankara, Turkey)
MEETING THE CHALLENGE OF EMERGING PATHOGENS IN PATIENTS WITH HEMATOLOGICAL
MALIGNANCIES: ADVANCES IN DIAGNOSIS, TREATMENT, AND PREVENTION
Scientific Chair : Thomas J Walsh (Weill Cornell Medical Center of Cornell University, New York, USA)
İrfan Yavaşoğlu (Adnan Menderes University, Aydın, Turkey)
14:00 - 15:30
*New Antimicrobial Agents and the Challenges of Multidrug Resistant Bacteria in Patients with
Hematological Malignancies: Thomas J Walsh (Weill Cornell Medical Center of Cornell University, New
York, USA)
*Advances in the Epidemiology and Treatment of Invasive Fungal Infections in Patients with
Hematological Malignancies: Maria Gamaletsou(National and Kapodistrian University of Athens,
Athens, Greece)
*Evolving Challenges and New Treatment Options of Respiratory and Systemic Viral Infections in
Patients with Hematological Malignancies: Nikolaos Sipsas(National and Kapodistrian University of
Athens, Athens, Greece)
14:00 - 15:31
COFFEE BREAK
MYELODYSPLASTIC SYNDROMES
Scientific Chair : H. Joachim Deeg (Fred Hutchinson Cancer Research Center, Seattle, USA)
Mustafa Çetiner (American Hospital, Istanbul, Turkey)
16:00 - 18:00 *Hematopoietic Cell Transplantation for MDS: Success and Challenges: H. Joachim Deeg (Fred
Hutchinson Cancer Research Center, Seattle, USA)
*Treatment of Higher Risk MDS (Excluding Transplant): Lionel Adès (Hopital Saint Louis, Paris, France)
*Impact of Gene Mutations and Expression on Clinical Variables and Prognosis in MDS: Jacqueline
Boultwood (University of Oxford, London)
POSTER DISCUSSION
TIME
07:00- 08:15
5th INTERNATIONAL CONGRESS ON LEUKEMIA LYMPHOMA MYELOMA
MAY 23 2015
MEETING HALL A
TAKEDA
MEET THE EXPERT (Meet The Expert Hall)
FOLLICULAR LYMPHOMA
Scientific Chair : Burhan Ferhanoğlu ( Koç University Medical School, Istanbul, Turkey)
Jane Winter ( Northwestern University, Chicago, USA)
08:30-10:00
*Introduction and Standard Therapy: Burhan Ferhanoğlu (Koç University, Istanbul, Turkey)
*The Biology of Follicular Lymphoma and How This May Inform Future Treatment : Daniel Hodson (National Cancer
Institute, NIH, Bethesda,USA)
*New Treatments For Follicular Lymphoma - Towards A Chemotherapy Free Future : Anas Younes (The University
of Texas Anderson Cancer Center, Texas, USA)
COFFEE BREAK
10:00 - 10:30
CHRONIC MYELOID LEUKEMIA
Scientific Chair: Richard A. Larson ( University Of Chicago, Chicago, USA)
Burhan Turgut (Trakya University, Edirne, Turkey )
10:30 - 12:00 *Managing Complications and Pregnancy During CML Treatment : TBA
*Molecular Monitoring and Treatment-free Remissions : Ehab Atallah (Medical College of Wisconsin and Froedtert
Hospital, Milwaukee, USA)
* Choosing wisely – Is there a best TKI for CML?: Richard A. Larson(University Of Chicago, Chicago, USA)
12:30 - 13:30
SATELLITE SYMPOSIUM / CELGENE
12:00 - 14:00
LUNCH
CHRONIC LYMPHOCYTIC LEUKEMIA
Scientific Chair : Peter Dreger (University of Heidelberg, Hamburg, Germany)
Osman İlhan(Ankara University, Ankara, Turkey)
14:00 - 15:30
*How To Treat CLL in Elderly Patients? : Emili Montserrat (University of Barcelona, Barcelona, Spain)
*How To Treat CLL in Younger Patients? : Eva Kimby (Karolinska Institute Huddinge University, Karolinska, Sweden)
*How To Treat Refractory CLL? : Peter Dreger (University of Heidelberg, Hamburg, Germany)
15:50 - 16:00
COFFEE BREAK
AGGRESSIVE LYMPHOMAS
Scientific Chair : Anna Sureda (Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain)
Mutlu Arat (Bilim University, Istanbul, Turkey)
16:00 - 18:00 *Treatment of T-cell Lymphomas in the Era of New Drugs : Norbert Schmitz (ASKLEPIOS Klinik St. Georg, Hamburg,
Germany)
*Current Therapy for Primary CNS Lymphoma : Benjamin Kasenda (Universitatsspital Basel, Basel, Switzerland)
*Treatment Options for Transformed Follicular Lymphoma : Jane Winter (Northwestern University, Chicago, USA)
*New Insights in the Treatment of Mantle Cell Lymphoma : Olivier Hermine (Imagine Institut des Maladies
Génétiques, France)
POSTER DISCUSSION